Skip to main content

Anti-Cancer Drug Design is now published as Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics.

Publisher: Cognizant Communication Corporation

Volume 14, Number 4, 1999

Blockade of telomerase function in various cells
pp. 305-316(12)
Authors: Yegorov, YE; Akimov, SS; Akhmalisheva, AK; Semenova, IV; Smirnova, YB; Kraevsky, AA; Zelenin, AV

Favourites:
ADD

Porphyrins can catalyze the interconversion of DNA quadruplex structural types
pp. 317-326(10)
Authors: Arthanari, H; Bolton, PH

Favourites:
ADD

The development of telomerase inhibitors: the G-quartet approach
pp. 327-339(13)
Authors: Mergny, J-L; Mailliet, P; Lavelle, F; Riou, J-F; Laoui, A; Hélène, C

Favourites:
ADD
Favourites:
ADD
Favourites:
ADD

Telomere-interactive agents affect proliferation rates and induce chromosomal destabilization in sea urchin embryos
pp. 355-365(11)
Authors: Izbicka, E; Nishioka, D; Marcell, V; Raymond, E; Davidson, KK; Lawrence, RA; Wheelhouse, RT; Hurley, LH; Wu, RS; Von Hoff, DD

Favourites:
ADD

Design, synthesis and evaluation of human telomerase inhibitors based upon a tetracyclic structural motif
pp. 373-382(10)
Authors: Perry, PJ; Gowan, SM; Read, MA; Kelland, LR; Neidle, S

Favourites:
ADD

The complete issue is available for purchase

$125.00

Purchasing this issue will give you access to all of the articles listed above for 2 days. You may also purchase articles individually by visiting the abstract page of the article. The exact price (including tax) will be displayed in your shopping cart before you check out. You will be able to remove this item from your shopping cart at any time before you have completed check-out.

Add to cart

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more